Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus (IBUPAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04037514
Recruitment Status : Recruiting
First Posted : July 30, 2019
Last Update Posted : July 30, 2019
Sponsor:
Collaborators:
Instituto de Investigacion Sanitaria La Fe
Spanish Clinical Research Network - SCReN
Information provided by (Responsible Party):
Máximo Vento Torres, Instituto de Investigacion Sanitaria La Fe

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 31, 2020
Estimated Study Completion Date : February 28, 2022
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):